Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseHematologic NeoplasmsTransplantation ConditioningTransplantation, AutologousHematopoietic Stem Cell MobilizationStem Cell TransplantationGranulocyte Colony-Stimulating FactorTransplantation ChimeraGraft SurvivalBusulfanBone Marrow TransplantationTissue DonorsAntigens, CD34LeukapheresisVidarabineTreatment OutcomeRecurrenceMyeloablative AgonistsImmunosuppressive AgentsGraft vs Leukemia EffectMelphalanCombined Modality TherapyStem CellsBlood Component RemovalCyclophosphamideHistocompatibilityHematopoietic Stem CellsHistocompatibility TestingMultiple MyelomaRetrospective StudiesSurvival AnalysisCord Blood Stem Cell TransplantationWhole-Body IrradiationRemission InductionLeukemiaAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalLymphoma, Non-HodgkinEtoposideAntineoplastic Agents, AlkylatingChronic DiseaseSalvage TherapyLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival RateTransplantation, IsogeneicThiotepaInfectionHLA AntigensPOEMS SyndromeCytomegalovirus InfectionsTime FactorsMyelodysplastic SyndromesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytarabineLymphocyte DepletionHematopoiesisT-LymphocytesGraft vs Tumor EffectHodgkin DiseaseLiver TransplantationLymphocyte TransfusionVincristineAnemia, AplasticAmyloidosisCarmustineCyclosporineBlood CellsTransplantation ImmunologyIfosfamideFollow-Up StudiesHematologic DiseasesLymphomaPlatelet CountNeoplasm, ResidualFatal OutcomeSiblingsImmunosuppressionMesenchymal Stem Cell TransplantationOpportunistic InfectionsNeoplasmsBlood Cell CountBone MarrowPrognosisImmunophenotypingFeasibility StudiesAntilymphocyte SerumCell TransplantationBlood DonorsAcute DiseaseProspective StudiesKidney TransplantationAntineoplastic AgentsEmbryonic Stem CellsCytophagocytosisRecombinant ProteinsHistiocytosis, Non-Langerhans-Cell